Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

2011

4001 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Mitochondrial dysfunction in Parkinson's disease.

Keane PC, Kurzawa M, Blain PG, Morris CM.

Parkinsons Dis. 2011 Mar 15;2011:716871. doi: 10.4061/2011/716871.

0

0

0

PUBMED

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial.

LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Van Meter L, Sa

Lancet Neurol. 2011 Apr;10(4):309-19. doi: 10.1016/S1474-4422(11)70039-4.

0

0

0

PUBMED

Serum urate and probability of dopaminergic deficit in early Parkinson's disease"."

Schwarzschild MA, Marek K, Eberly S, Oakes D, Shoulson I, Jennings D, Seibyl J, Ascherio A; Parkinson Study Group PRECEPT Investigators..

Mov Disord. 2011 Aug 15;26(10):1864-8. doi: 10.1002/mds.23741.

0

0

0

PUBMED

Modified constraint-induced movement therapy improves fine and gross motor performance of the upper limb in Parkinson disease.

Lee KS, Lee WH, Hwang S.

Am J Phys Med Rehabil. 2011 May;90(5):380-6. doi: 10.1097/PHM.0b013e31820b15cd.

0

0

0

PUBMED

Pupillary unrest correlates with arousal symptoms and motor signs in Parkinson disease.

Jain S, Siegle GJ, Gu C, Moore CG, Ivanco LS, Studenski S, Greenamyre JT, Steinhauer SR.

Mov Disord. 2011 Jun;26(7):1344-7. doi: 10.1002/mds.23628.

0

0

0

PUBMED

Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease.

Evidente VG, Premkumar AP, Adler CH, Caviness JN, Driver-Dunckley E, Lyons MK.

Acta Neurol Scand. 2011 Sep;124(3):211-4. doi: 10.1111/j.1600-0404.2010.01455.x.

0

0

0

PUBMED

Reversible abnormal functional neuroimaging presentations in polycythemia vera with chorea.

Huang HC, Wu YC, Shih LY, Lo WC, Tsai CH, Shyu WC.

J Neurol. 2011 Nov;258(11):2054-7. doi: 10.1007/s00415-011-6069-y.

0

0

0

PUBMED

Amyloid P component as a plasma marker for Parkinson's disease identified by a proteomic approach.

Chen HM, Lin CY, Wang V.

Clin Biochem. 2011 Apr;44(5-6):377-85. doi: 10.1016/j.clinbiochem.2011.01.002.

0

0

0

PUBMED

Antiphospholipid syndrome and other lupus-related movement disorders.

Plowman EK, Okun MS.

Handb Clin Neurol. 2011;100:237-45. doi: 10.1016/B978-0-444-52014-2.00016-1. Review. No abstract available.

0

0

0

PUBMED

Body composition in premanifest Huntington's disease reveals lower bone density compared to controls.

Goodman AO, Barker RA.

Version 2. PLoS Curr. 2011 Feb 28 [revised 2011 Jan 1];3:RRN1214.

0

0

0

PUBMED

Effects of 6-month, Multimodal Exercise Program on Clinical and Gait Parameters of Patients with Idiopathic Parkinson's Disease: A Pilot Study.

Vitório R, Teixeira-Arroyo C, Lirani-Silva E, Barbieri FA, Caetano MJ, Gobbi S, Stella F, Teresa Bucken Gobbi L.

ISRN Neurol. 2011;2011:714947. doi: 10.5402/2011/714947.

0

0

0

PUBMED

[Psychiatric side effects of deep brain stimulation in Parkinson's disease].

Skuban T, Flohrer J, Klosterkötter J, Kuhn J.

Fortschr Neurol Psychiatr. 2011 Dec;79(12):703-10. doi: 10.1055/s-0031-1281854. Review. German.

0

0

0

PUBMED

Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function.

Selak MA, Lyver E, Micklow E, Deutsch EC, Onder O, Selamoglu N, Yager C, Knight S, Carroll M, Daldal F, Dancis A, Lynch DR, Sarry JE.

Mitochondrion. 2011 Mar;11(2):342-50. doi: 10.1016/j.mito.2010.12.003.

0

0

0

PUBMED

Interoceptive sensory trick for runner's dystonia.

Suzuki K, Izawa N, Aiba S, Hashimoto K, Hirata K, Nakamura T.

Mov Disord. 2011 Mar;26(4):758-9. doi: 10.1002/mds.23440. No abstract available.

0

0

0

PUBMED

Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease.

McFarland K, Price DL, Bonhaus DW.

Behav Pharmacol. 2011 Oct;22(7):681-92. doi: 10.1097/FBP.0b013e32834aff98.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy